the human proteome – a scientific opportunity for transforming diagnostics, therapeutics, and healthcare人类蛋白质组u2014u2014科学的机会改变诊断,治疗和保健.pdfVIP

Vidal et al. Clinical Proteomics 2012, 9:6 /content/9/1/6 CLINICAL PROTEOMICS MEETING REPORT Open Access The human proteome – a scientific opportunity for transforming diagnostics, therapeutics, and healthcare 1 2 3 4 5* 6 7* Marc Vidal , Daniel W Chan , Mark Gerstein , Matthias Mann , Gilbert S Omenn , Danilo Tagle , Salvatore Sechi and Workshop Participants Abstract A National Institutes of Health (NIH) workshop was convened in Bethesda, MD on September 26–27, 2011, with representative scientific leaders in the field of proteomics and its applications to clinical settings. The main purpose of this workshop was to articulate ways in which the biomedical research community can capitalize on recent technology advances and synergize with ongoing efforts to advance the field of human proteomics. This executive summary and the following full report describe the main discussions and outcomes of the workshop. Executive summary human proteome, including the antibody-based Human A National Institutes of Health (NIH) workshop was Protein Atlas, the NIH Common Fund Protein Capture convened in Bethesda, MD on September 26–27, 2011, Reagents, the mass spectrometry-based Peptide Atlas with representative scientific leaders in the field of pro- and Selected Reaction Monitoring (SRM) Atlas, and the teomics and its applications to clinical settings. The main Human